Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open‐Label, Randomized, Bayesian Noninferiority Trial-Reference-Cited by-同舟云学术

Mycophenolate Mofetil Versus Cyclophosphamide for Remission Induction in Childhood Polyarteritis Nodosa: An Open‐Label, Randomized, Bayesian Noninferiority Trial

Published:2021-07-31 Issue:9 Volume:73 Page:1673-1682
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Brogan Paul A.¹^ORCID,Arch Barbara²,Hickey Helen²,Anton Jordi³^ORCID,Iglesias Este³,Baildam Eileen⁴,Mahmood Kamran⁴,Cleary Gavin⁴,Moraitis Elena⁵,Papadopoulou Charalampia⁵,Beresford Michael W.²,Riley Phil⁶,Demir Selcan⁷,Ozen Seza⁷^ORCID,Culeddu Giovanna⁸,Hughes Dyfrig A.⁸,Dolezalova Pavla⁹,Hampson Lisa V.¹⁰,Whitehead John¹⁰,Jayne David¹¹,Ruperto Nicola¹²,Tudur‐Smith Catrin²,Eleftheriou Despina¹

Affiliation:

1. University College London Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children NHS Foundation Trust London UK

2. University of Liverpool Liverpool UK

3. St. Joan de Déu Hospital Barcelona Spain

4. Alder Hey Children’s NHS Foundation Trust Liverpool UK

5. Great Ormond Street Hospital for Children NHS Foundation Trust London UK

6. Royal Manchester Children’s Hospital Manchester UK

7. Hacettepe University Ankara Turkey

8. Bangor University Bangor UK

9. General University Hospital in Prague and Charles University Prague Czech Republic

10. Lancaster University Lancaster UK

11. University of Cambridge Cambridge UK

12. Instituto Giannina Gaslini IRCCS UOSID Centro Trial Genoa Italy

Funder